日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Durability of Immunogenicity and Protection of rVSV∆G-ZEBOV-GP Vaccine in a Nonhuman Primate EBOV Challenge Model

rVSV∆G-ZEBOV-GP疫苗在非人灵长类动物埃博拉病毒攻击模型中的免疫原性和保护持久性

Bixler, Sandra L; Shurtleff, Amy C; Sunay, Melek M E; Liu, Kenneth; Chen, Ziqiang; Eichberg, Michael; Simon, Jakub K; Coller, Beth-Ann G; Dubey, Sheri

rVSVΔG-ZEBOV-GP Vaccine Is Highly Immunogenic and Efficacious Across a Wide Dose Range in a Nonhuman Primate EBOV Challenge Model

在非人灵长类动物埃博拉病毒攻击模型中,rVSVΔG-ZEBOV-GP疫苗在较宽的剂量范围内均具有高度免疫原性和有效性。

Shurtleff, Amy C; Trefry, John C; Dubey, Sheri; Sunay, Melek M E; Liu, Kenneth; Chen, Ziqiang; Eichberg, Michael; Silvera, Peter M; Kwilas, Steve A; Hooper, Jay W; Martin, Shannon; Simon, Jakub K; Coller, Beth-Ann G; Monath, Thomas P

Medical countermeasures against henipaviruses: a review and public health perspective

针对亨尼帕病毒的医疗对策:综述及公共卫生视角

Gómez Román, Raúl; Tornieporth, Nadia; Cherian, Neil George; Shurtleff, Amy C; L'Azou Jackson, Maïna; Yeskey, Debra; Hacker, Adam; Mungai, Eric; Le, Tung Thanh

Opportunities for Refinement of Non-Human Primate Vaccine Studies

改进非人灵长类动物疫苗研究的机会

Prescott, Mark J; Clark, Carolyn; Dowling, William E; Shurtleff, Amy C

Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus disease

食蟹猴暴露于埃博拉病毒基奎特株后,其疾病的自然史表明,这种非人灵长类动物模型是研究埃博拉病毒病的可靠模型。

Niemuth, Nancy A; Fallacara, Dawn; Triplett, Cheryl A; Tamrakar, Sanjay M; Rajbhandari, Alisha; Florence, Clint; Ward, Lucy; Griffiths, Anthony; Carrion, Ricardo Jr; Goez-Gazi, Yenny; Alfson, Kendra J; Staples, Hilary M; Brasel, Trevor; Comer, Jason E; Massey, Shane; Smith, Jeanon; Kocsis, Andrew; Lowry, Jake; Johnston, Sara C; Nalca, Aysegul; Goff, Arthur J; Shurtleff, Amy C; Pitt, Margaret L; Trefry, John; Fay, Michael P

High degree of correlation between Ebola virus BSL-4 neutralization assays and pseudotyped VSV BSL-2 fluorescence reduction neutralization test

埃博拉病毒BSL-4中和试验与假型水疱性口炎病毒BSL-2荧光还原中和试验之间具有高度相关性

Konduru, Krishnamurthy; Shurtleff, Amy C; Bavari, Sina; Kaplan, Gerardo

Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge

埃博拉病毒糖蛋白Fc融合蛋白可保护豚鼠免受致命攻击

Konduru, Krishnamurthy; Shurtleff, Amy C; Bradfute, Steven B; Nakamura, Siham; Bavari, Sina; Kaplan, Gerardo

Pre-symptomatic diagnosis and treatment of filovirus diseases

丝状病毒疾病的症状前诊断和治疗

Shurtleff, Amy C; Whitehouse, Chris A; Ward, Michael D; Cazares, Lisa H; Bavari, Sina

Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation

通过皮肤电穿孔递送编码拉沙病毒糖蛋白前体基因的密码子优化DNA疫苗,可增强其在豚鼠疾病模型中的疗效

Cashman, Kathleen A; Broderick, Kate E; Wilkinson, Eric R; Shaia, Carl I; Bell, Todd M; Shurtleff, Amy C; Spik, Kristin W; Badger, Catherine V; Guttieri, Mary C; Sardesai, Niranjan Y; Schmaljohn, Connie S

A systematic screen of FDA-approved drugs for inhibitors of biological threat agents

对FDA批准的药物进行系统筛选,以寻找生物威胁因子抑制剂。

Madrid, Peter B; Chopra, Sidharth; Manger, Ian D; Gilfillan, Lynne; Keepers, Tiffany R; Shurtleff, Amy C; Green, Carol E; Iyer, Lalitha V; Dilks, Holli Hutcheson; Davey, Robert A; Kolokoltsov, Andrey A; Carrion, Ricardo Jr; Patterson, Jean L; Bavari, Sina; Panchal, Rekha G; Warren, Travis K; Wells, Jay B; Moos, Walter H; Burke, Raelyn L; Tanga, Mary J